3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
3
Inflammatory Bowel Diseases
2
Crohn Disease
2
Colitis, Ulcerative
2
Lymphoma
1
Inflammation
1
Hypertension
1
Depressive Disorder, Treatment-Resistant
1
Depressive Disorder, Major
1
Depression
1
Bipolar Disorder
1
Autoimmune Diseases
1
Arthritis, Psoriatic
1
Interventions
Escitalopram
3
Sugars
2
Saline Solution
2
Interleukin-2
1
Infliximab
1
Hepatitis B Vaccines
1
Esketamine
1
Cognitive Behavioral Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Depression
×
Infliximab
×
Clear all
NCT00463580
2025-07-08
Infliximab
Emory University
Phase 4
Completed
60 enrolled
15 charts